A summary of results from the Trial Assigning Individualized Options for Treatment, or TAILORx, finds that women with early-stage hormone receptor-positive breast cancer have a low risk of recurrence based on a test for the expression of 21 genes.
from Cancer Information - TAILORx Trial Shows Women at Low Risk for Breast Cancer Recurrence May Forgo Chemotherapy
0 коммент.